Search tips
Search criteria 


Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
Proc R Soc Med. 1976; 69(Suppl 1): 3–8.
PMCID: PMC1863606

Pharmacology and Biochemistry of Haloperidol

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (929K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Andén NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol. 1970;11(3):303–314. [PubMed]
  • Burt DR, Enna SJ, Creese I, Snyder SH. Dopamine receptor binding in the corpus striatum of mammalian brain. Proc Natl Acad Sci U S A. 1975 Nov;72(11):4655–4659. [PubMed]
  • Clement-Cormier YC, Kebabian JW, Petzold GL, Greengard P. Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1113–1117. [PubMed]
  • Ernst AM. Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia. 1967;10(4):316–323. [PubMed]
  • Gérardy J, Dresse A. Action des neuroleptiques sur le taux en dopamine et en DOPAC du noyau caude de rat. Experientia. 1974 May 15;30(5):523–524. [PubMed]
  • Guyenet PG, Javory AF, Beaujouan JC, Rossier BJ, Glowinski J. Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system. Brain Res. 1975 Feb 7;84(2):227–244. [PubMed]
  • Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev. 1966 Jun;18(2):925–964. [PubMed]
  • JANSSEN PA, NIEMEGEERS CJ. Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butvrophenone. Arzneimittelforschung. 1959 Dec;9:765–767. [PubMed]
  • JANSSEN PA, NIEMEGEERS CJ, DONY JG. A comparative study of the effect of subcutaneous and oral doses of haloperidol on avoidance-escape habits of rats and dogs in a "jumping box" situation. Arzneimittelforschung. 1963 May;13:401–403. [PubMed]
  • JANSSEN PA, NIEMEGEERS CJ, JAGENEAU AH. Apomorphine-antagonism in rats. Arzneimittelforschung. 1960 Dec;10:1003–1005. [PubMed]
  • JANSSEN PA, NIEMEGEERS CJ, SCHELLEKENS KH. Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. III. Duration of antiemetic action and oral effectiveness of Haloperidol (R 1625) and of chlorpromazine in dogs. Arzneimittelforschung. 1960 Nov;10:955–955. [PubMed]
  • Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats. Arzneimittelforschung. 1967 Jul;17(7):841–854. [PubMed]
  • JANSSEN PA, VAN DE WESTERINGH C, JAGENEAU AH, DEMOEN PJ, HERMANS BK, VAN DAELE GH, SCHELLEKENS KH, VAN DER EYCKEN CA. Chemistry and pharmacology of CNS depressants related to 4-(4-hydroxy-phenylpiperidino)butyrophenone. I. Synthesis and screening data in mice. J Med Pharm Chem. 1959 Jun;1:281–297. [PubMed]
  • Iversen LL, Horn AS, Miller RJ. Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates. Adv Neurol. 1975;9:197–212. [PubMed]
  • Niemegeers CJ. The apomorphine antagonism test in dogs. Experimental evidence and critical considerations on specific methodological criteria. Pharmacology. 1971;6(6):353–364. [PubMed]
  • NIEMEGEERS CJ, JANSSEN PA. Influence of haloperidol (R 1625) and of haloperidide (R 3201) on avoidance and escape behavior of trained dogs in a "jumping box". J Pharm Pharmacol. 1960 Dec;12:744–753. [PubMed]
  • Niemegeers CJ, Verbruggen FJ, Janssen PA. The influence of various neuroleptic drugs on shock avoidance responding in rats. I. Nondiscriminated Sidman avoidance procedure. Psychopharmacologia. 1969;16(3):161–174. [PubMed]
  • Nybäck H, Schubert J, Sedvall G. Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain. J Pharm Pharmacol. 1970 Aug;22(8):622–624. [PubMed]
  • O'Keeffe R, Sharman DF, Vogt M. Effect of drugs used in psychoses on cerebral dopamine metabolism. Br J Pharmacol. 1970 Feb;38(2):287–304. [PMC free article] [PubMed]
  • Persson T. Drug induced changes in 3H-catholamine accumulation after 3H-tyrosine. Acta Pharmacol Toxicol (Copenh) 1970;28(5):378–390. [PubMed]
  • Seeman P, Chau-Wong M, Tedesco J, Wong K. Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc Natl Acad Sci U S A. 1975 Nov;72(11):4376–4380. [PubMed]
  • van Rossum JM. The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn Ther. 1966 Apr;160(2):492–494. [PubMed]
  • Wauquier A, Niemegeers CJ. Intracranial self-stimulation in rats as a function of various stimulus parameters. II. Influence of haloperidol, pimozide and pipamperone on medial forebrain bundle stimulation with monopolar electrodes. Psychopharmacologia. 1972;27(3):191–202. [PubMed]
  • Zivkovic B, Guidotti A. Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors. Brain Res. 1974 Oct 25;79(3):505–509. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press